Clinical Trials Logo

MSI-H/dMMR Solid Tumor clinical trials

View clinical trials related to MSI-H/dMMR Solid Tumor.

Filter by:
  • None
  • Page 1

NCT ID: NCT04547101 Terminated - Clinical trials for MSI-H/dMMR Solid Tumor

A Study of AK104 in Subjects With Locally Advanced Unresectable or Metastatic MSI-H/dMMR Solid Tumors

Start date: April 24, 2020
Phase: Phase 2
Study type: Interventional

It is a single-arm, open-label, multicenter, phase II study to evaluate the safety, efficacy, pharmacokinetics (PK) and immunogenicity of AK104 as a single agent in subjects with previously-treated locally advanced unresectable or metastatic MSI-H or dMMR solid tumors.